Company: TVRD
Filing Date: 2025-11-13
Form Type: 8-K
Source: 0001104659-25-111310
Chunk: 0

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On November 13, 2025,
Tvardi Therapeutics, Inc. (the “ Company”) issued a press release announcing its financial results and business highlights
for the fiscal quarter ended September 30, 2025. A copy of the Company’s press release dated November 13, 2025 is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained
herein and the accompanying Exhibit 99.1 is being furnished under “ Item 2.02 Results of Operations and Financial Condition”
and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, nor shall it be
deemed incorporated by reference in any filing with the Securities and Exchange Commission made by us, whether made before or after the
date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.